1
|
Oh PC, Ahn T, Kim DW, Hong BK, Kim DS, Kwan J, Choi CU, Yang YM, Bae JH, Jung KT, Choi WG, Jeon DW, Cho DK, Pyun WB, Cha KS, Cha TJ, Chun KJ, Kim YD, Kim BS, Kim DI, Kim TI. Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial. Int J Cardiol 2015; 202:331-5. [PMID: 26432484 DOI: 10.1016/j.ijcard.2015.09.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2015] [Revised: 09/07/2015] [Accepted: 09/19/2015] [Indexed: 11/25/2022]
Abstract
BACKGROUND/OBJECTIVES The effect of aspirin and clopidogrel in a fixed-dose combination (FDC) on platelet function was compared with separate formulations in patients that had undergone percutaneous coronary intervention (PCI) with drug-eluting stent (DES). METHODS This was a phase IV, prospective, multicenter, single-arm, non-inferiority study. Patients that had taken aspirin 100 mg and clopidogrel 75 mg once daily as separate formulations for >6 months after PCI with DES were enrolled, and then switched to an aspirin/clopidogrel FDC once-daily for 4 weeks. Platelet reactivity was determined using the VerifyNow® P2Y12 assay at baseline (immediately prior to switching) and 4 weeks later. RESULTS A total of 648 patients (the full-analysis population; age, 63.6±9.0 years; male, 76.5%) finished the study, and 565 (the per-protocol population) completed without protocol violations. In the per-protocol population, the % inhibitions of P2Y12 and ARU were not significantly different between baseline and after 4 weeks of FDC treatment (29.2±20.0% to 29.0±19.9%, P=0.708; 445.1±69.2 to 446.2±63.0, P=0.799, respectively) and the difference in P2Y12 inhibition observed did not exceed the predetermined limit of non-inferiority (95% CI, -0.9 to 1.3). In the full-analysis population, the % inhibitions of P2Y12, PRU, and ARU were not significantly changed after 4 weeks of FDC treatment. CONCLUSIONS This study demonstrates that the efficacy of platelet inhibition by an aspirin/clopidogrel FDC was not inferior to that of separate aspirin and clopidogrel formulations in patients that had undergone PCI with DES.
Collapse
Affiliation(s)
- Pyung Chun Oh
- Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea
| | - Taehoon Ahn
- Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
| | - Dong Woon Kim
- Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea
| | - Bum-Kee Hong
- Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea
| | - Dong-Soo Kim
- Division of Cardiology, Department of Internal Medicine, Inje University, Busan Paik Hospital, Busan, Republic of Korea
| | - Jun Kwan
- Division of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea
| | - Cheol Ung Choi
- Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Incheon, Republic of Korea
| | - Yong-Mo Yang
- Division of Cardiology, Department of Internal Medicine, Cheongju St. Mary's Hospital, Cheongju, Republic of Korea
| | - Jang Ho Bae
- Division of Cardiology, Department of Internal Medicine, Konyang University Hospital, Daejeon, Incheon, Republic of Korea
| | - Kyung Tae Jung
- Division of Cardiology, Department of Internal Medicine, Eulji University Hospital, Daejeon, Republic of Korea
| | - Woong Gil Choi
- Division of Cardiology, Department of Internal Medicine, Konkuk University Chungju Hospital, Chungju, Republic of Korea
| | - Dong Woon Jeon
- Division of Cardiology, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Republic of Korea
| | - Deok Kyu Cho
- Division of Cardiology, Department of Internal Medicine, Myongji Hospital, Goyang, Republic of Korea
| | - Wook Bum Pyun
- Division of Cardiology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea
| | - Kwang Soo Cha
- Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea
| | - Tae-Joon Cha
- Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea
| | - Kook Jin Chun
- Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
| | - Young Dae Kim
- Division of Cardiology, Department of Internal Medicine, Dong-A University Medical Center, Busan, Republic of Korea
| | - Byung Soo Kim
- Division of Cardiology, Department of Internal Medicine, DaeDong Hospital, Busan, Republic of Korea
| | - Doo-Il Kim
- Division of Cardiology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Republic of Korea
| | - Tae Ik Kim
- Division of Cardiology, Department of Internal Medicine, Maryknoll Medical Center, Busan, Republic of Korea
| |
Collapse
|
2
|
Kang DY, Yang HM, Park KW, Lee SR, Lee MH, Lee DW, Lee HY, Kang HJ, Koo BK, Chae IH, Choi DJ, Kim HS, Kim CH. Lack of association between low density lipoprotein particle size and on-treatment platelet reactivity in patients with coronary artery disease. Korean Circ J 2012; 42:551-7. [PMID: 22977451 PMCID: PMC3438265 DOI: 10.4070/kcj.2012.42.8.551] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2011] [Revised: 02/13/2012] [Accepted: 02/21/2012] [Indexed: 11/11/2022] Open
Abstract
BACKGROUND AND OBJECTIVES Small dense low density lipoproteins (sd-LDL) are a risk factor for coronary artery disease and are known to stimulate platelet function in vitro. This study aimed to evaluate whether high proportion of sd-LDL is associated with high on-treatment platelet reactivity (HOPR). SUBJECTS AND METHODS From January 2009 to March 2010, 439 subjects (mean age: 64.3±9.7, Male : Female=306 : 133) were enrolled from the low density LIPOProtein-cholesterol Size measurement Registry with coronary artery disease, who had undergone elective percutaneous coronary intervention and measured both LDL particle size and on-treatment platelet reactivity (OPR). Mean LDL particle size was measured by gradient gel electrophoresis (Quantimetrix, Lipoprint™) and OPR by the VerifyNow™ system (aspirin and P2Y12). RESULTS Between pattern A (large, buoyant LDL dominant) and B (sd-LDL dominant) population, there were no significant difference in OPR to aspirin (441.3±71.9 vs. 434.07±63.45 aspirin reaction units, p=0.351) or clopidogrel (237.9±87.3 vs. 244.9±80.7 P2Y12 reaction units, p=0.465). There was no difference in LDL particle size between patients with HOPR compared with non-HOPR patients (aspirin: 26.8±0.5 vs. 26.7±0.6 nm, p=0.078, clopidogrel: 26.7±0.6 vs. 26.8±0.5 nm, p=0.857). Pearson's correlation coefficients between LDL particle size and platelet reactivity were not statistically significant (aspirin assay: r=0.080, p=0.098, P2Y12 assay: r=-0.027, p=0.568). CONCLUSION There was no significant association between LDL particle size and OPR in patients with coronary artery disease.
Collapse
Affiliation(s)
- Do-Yoon Kang
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Han-Mo Yang
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Kyung Woo Park
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - So-Ryoung Lee
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Min-Ho Lee
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Dong-Won Lee
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Hae-Young Lee
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Hyun-Jae Kang
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Bon-Kwon Koo
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - In-Ho Chae
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Dong-Ju Choi
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Hyo-Soo Kim
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
| | - Cheol-Ho Kim
- Department of Internal Medicine, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea
| |
Collapse
|
3
|
Yun KH, Rhee SJ, Park HY, Yoo NJ, Kim NH, Oh SK, Jeong JW. Effects of Omeprazole on the Antiplatelet Activity of Clopidogrel. Int Heart J 2010; 51:13-6. [DOI: 10.1536/ihj.51.13] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Affiliation(s)
- Kyeong Ho Yun
- Department of Cardiovascular Medicine, Wonkwang University Hospital
- Institute of Wonkwang Medical Science
| | - Sang Jae Rhee
- Department of Cardiovascular Medicine, Wonkwang University Hospital
| | | | - Nam Jin Yoo
- Department of Cardiovascular Medicine, Wonkwang University Hospital
| | - Nam-Ho Kim
- Department of Cardiovascular Medicine, Wonkwang University Hospital
- Institute of Wonkwang Medical Science
| | - Seok Kyu Oh
- Department of Cardiovascular Medicine, Wonkwang University Hospital
- Institute of Wonkwang Medical Science
| | - Jin-Won Jeong
- Department of Cardiovascular Medicine, Wonkwang University Hospital
- Institute of Wonkwang Medical Science
| |
Collapse
|
4
|
Park SH, Kim W, Park CS, Kang WY, Hwang SH, Kim W. A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure. Am J Cardiol 2009; 104:1292-5. [PMID: 19840579 DOI: 10.1016/j.amjcard.2009.06.049] [Citation(s) in RCA: 90] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2009] [Revised: 06/11/2009] [Accepted: 06/11/2009] [Indexed: 10/20/2022]
Abstract
We sought to compare the platelet responsiveness to clopidogrel between patients with chronic renal failure and those with normal renal function. We conducted a prospective, randomized, open-label, single-center trial. A total of 23 patients with normal renal function received a usual daily dose of 75 mg of clopidogrel (group I, 61 +/- 7 years). Also, 36 patients with chronic renal failure (60 +/- 5 years) were divided into 2 groups according to their daily dose of clopidogrel: a daily dose of 75 mg of clopidogrel for 30 days (group II, n = 18) or a daily dose of 150 mg (group III, n = 18). The primary efficacy variables among the study groups using the VerifyNow P2Y12 assay were the P2Y12 reaction unit value and the percentage of inhibition. A significant difference was found in the P2Y12 reaction unit value among the 3 groups (239 +/- 87 in group I, 308 +/- 70 in group II, 302 +/- 81 in group III (p = 0.013) and in the percentage of inhibition (35 +/- 20 in group I, 21 +/- 16 in group II, 23 +/- 14 in group III, p = 0.026). No significant difference was found in the P2Y12 reaction units or percentage of inhibition between groups II and III. In conclusion, platelet responsiveness to clopidogrel decreased more in patients with chronic renal failure than in those with normal renal function, and this decreased platelet responsiveness to clopidogrel was not improved by an increase in the clopidogrel dosage.
Collapse
|
5
|
Kim SS, Jeong MH, Kim HK, Bae SY, Ryu KH, Cho KH, Kim MC, Park KH, Sim DS, Hong YJ, Kim JH, Ahn Y, Kang JC. Acute and subacute stent thrombosis in a patient with clopidogrel resistance: a case report. Korean Circ J 2009; 39:434-8. [PMID: 19949590 PMCID: PMC2771795 DOI: 10.4070/kcj.2009.39.10.434] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2009] [Accepted: 06/30/2009] [Indexed: 11/30/2022] Open
Abstract
Drug-eluting stents (DES) are considered the treatment of choice for most patients with obstructive coronary artery disease when percutaneous intervention (PCI) is feasible. However, stent thrombosis seems to occur more frequently with DES and occasionally is associated with resistance to anti-platelet drugs. We have experienced a case of recurrent stent thrombosis in a patient with clopidogrel resistance. A 63-year-old female patient suffered from acute myocardial infarction and underwent successful PCI of the left anterior descending coronary artery (LAD) with two DESs. She was found to be hyporesponsive to clopidogrel and was treated with triple anti-platelet therapy (aspirin 100 mg, clopidogrel 75 mg, and cilostazol 200 mg daily). Three days after discharge, she developed chest pain and was again taken to the cardiac catheterization laboratory, where coronary angiography (CAG) showed total occlusion of the mid-LAD where the stent had been placed. After intravenous administration of a glycoprotein IIb/IIIa inhibitor, balloon angioplasty was performed, resulting in Thrombolysis In Myocardial Infarction (TIMI) III antegrade flow. The next day, however, she complained of severe chest pain, and the electrocardiogram showed marked ST-segment elevation in V1-V6, I, and aVL with complete right bundle branch block. Emergent CAG revealed total occlusion of the proximal LAD due to stent thrombosis. She was successfully treated with balloon angioplasty and was discharged with triple anti-platelet therapy.
Collapse
Affiliation(s)
- Sung Soo Kim
- The Heart Research Center of Chonnam National University Hospital, Gwangju, Korea
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Kum DS, Kim MH, Paik JH, Yu LH, Han J, Kim KH, Park TH, Cha KS, Kim YD, Quan ML, Han JY. Clinical Effects of Additional Cilostazol Administration After Drug-Eluting Stent Insertion. Korean Circ J 2009. [DOI: 10.4070/kcj.2009.39.1.21] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Dong Sung Kum
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Moo Hyun Kim
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Jeung Hoan Paik
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Long Hao Yu
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Jin Han
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Kyung Ho Kim
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Tae Ho Park
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Kwang Soo Cha
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Young Dae Kim
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Mei Lian Quan
- Department of Laboratory Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Jin Yeong Han
- Department of Laboratory Medicine, College of Medicine, Dong-A University, Busan, Korea
| |
Collapse
|
7
|
Lee TK, Lee HC, Hwang KW, Chun KJ, Hong TJ, Shin YW. A Case of Late Recurrent Vasospasm After Sirolimus-Eluting Stent Implantation. Korean Circ J 2008. [DOI: 10.4070/kcj.2008.38.3.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Tae Kun Lee
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| | - Han Cheol Lee
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| | - Ki Won Hwang
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| | - Kook Jin Chun
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| | - Taek Jong Hong
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| | - Yung Woo Shin
- Department of Internal Medicine, Cardiac Catheterization Laboratory, Pusan National University Hospital, Busan, Korea
| |
Collapse
|